twice-daily tacrolimus

DRUG2 trials

Sponsors

University of Southern California, University Hospital Tuebingen

Conditions

Kidney Transplant RejectionKidney TransplantationPosttransplant Diabetes Mellitus

Phase 4

Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR

TerminatedNCT04773392

University of Southern CaliforniaKidney Transplantation, Kidney Transplant Rejection

Start: 2021-11-23End: 2024-02-23Updated: 2025-11-10

Tacrolimus Formulation and Glucose Metabolism After Kidney Transplantation (TAGLUMET Trial)

CompletedNCT05396898

University Hospital TuebingenPosttransplant Diabetes Mellitus

Start: 2020-12-16End: 2023-12-30Updated: 2024-02-02